News
DGAP-News: Symrise forciert internationale Expansion in Pet Nutrition durch Übernahme von Schaffelaarbos
DGAP-News: MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
DGAP-News: MorphoSys gibt vorläufigen Monjuvi-Umsatz für 2021 bekannt und veröffentlicht Finanzprognose für 2022
DGAP-News: MorphoSys gibt vorläufigen Monjuvi-Umsatz für 2021 bekannt und veröffentlicht Finanzprognose für 2022
DGAP-News: MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
DGAP-Adhoc: MorphoSys AG gibt vorläufigen Monjuvi-Umsatz für 2021 bekannt und veröffentlicht Finanzprognose für 2022
DGAP-Adhoc: MorphoSys AG gibt vorläufigen Monjuvi-Umsatz für 2021 bekannt und veröffentlicht Finanzprognose für 2022
DGAP-Adhoc: MorphoSys AG Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
DGAP-Adhoc: MorphoSys AG Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
Atmos Energy Corporation to Host Fiscal 2022 First Quarter Earnings Conference Call on February 9, 2022
Atmos Energy Corporation (NYSE: ATO) will host a conference call on Wednesday, February 9, at 9 a.m. Eastern to review the company’s Fiscal 2022 first quarter financial results. Atmos Energy will
ADTRAN Stockholders Overwhelmingly Approve Business Combination with ADVA Optical Networking SE
ADTRAN, Inc., (NASDAQ: ADTN) today announced that its stockholders have approved the business combination with ADVA Optical Networking SE by an overwhelming majority. In a Special Meeting of
ADTRAN Stockholders Overwhelmingly Approve Business Combination with ADVA Optical Networking SE
ADTRAN, Inc., (NASDAQ: ADTN) today announced that its stockholders have approved the business combination with ADVA Optical Networking SE by an overwhelming majority. In a Special Meeting of
Xencor to Present at the H.C. Wainwright Bioconnect Virtual Conference
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced
Kopin to Participate in Upcoming Virtual Investor Event
Kopin Corporation (NASDAQ: KOPN), a leading provider of innovative wearable computing technologies and solutions, announced today that Mr. Richard Sneider, Chief Financial Officer, will present at
Simulations Plus Reports First Quarter Fiscal 2022 Financial Results
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its first
Royal Gold Presenting at the 25th Annual CIBC Western Institutional Investor Conference (Virtual)
Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that management will present in the 25th Annual CIBC Western
T-Mobile Posts Record-High Customer Results, Adding 1.2 Million Postpaid Accounts and 5.5 Million Postpaid Customers in 2021
T-Mobile US, Inc. (NASDAQ: TMUS) provided a preliminary view of key customer results for the fourth quarter and full-year 2021, including its highest postpaid net customer additions and postpaid
T-Mobile Posts Record-High Customer Results, Adding 1.2 Million Postpaid Accounts and 5.5 Million Postpaid Customers in 2021
T-Mobile US, Inc. (NASDAQ: TMUS) provided a preliminary view of key customer results for the fourth quarter and full-year 2021, including its highest postpaid net customer additions and postpaid
T-Mobile Posts Record-High Customer Results, Adding 1.2 Million Postpaid Accounts and 5.5 Million Postpaid Customers in 2021
T-Mobile US, Inc. (NASDAQ: TMUS) provided a preliminary view of key customer results for the fourth quarter and full-year 2021, including its highest postpaid net customer additions and postpaid
Quidel Announces Preliminary Revenue for Fourth Quarter 2021
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it expects
Cirrus Logic to Announce Q3 Results January 31
Cirrus Logic, Inc. (Nasdaq: CRUS) today announced that the company will post its third quarter fiscal year 2022 financial results and business outlook on the investor relations area of its website
Transgene Announces Financial Calendar for 2022
Regulatory News:
TRANSGENE (Paris: TNG) today announced its financial reporting dates for 2022:
March 16, 2022: 2021 Fiscal Year Results
May 10, 2022: First Quarter 2022 Financial Results
Acadia Healthcare to Present at the 40th Annual J.P. Morgan Healthcare Conference
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will present virtually at the 40th Annual J.P. Morgan Healthcare Conference, which takes place January 10 – January
Eastman Schedules Fourth-Quarter and Full-Year 2021 Financial Results News Release and SEC Form 8-K Filing, Teleconference and Webcast, and Release of Additional Information
Eastman Chemical Company (NYSE:EMN):
Financial Results Release:
Thursday, Jan. 27, 2022
Approximately 4:30 p.m. Eastern Time
Via wire distribution and www.eastman.com, News Center and
Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference
Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”)